Healthcare

Healthcare

Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows

October 17, 2019 The Wall Street Analyzer Comments Off on Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows

New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with […]

No Picture
Biotech

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

October 1, 2019 The Wall Street Analyzer Comments Off on Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]

No Picture
Healthcare

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

August 20, 2019 The Wall Street Analyzer Comments Off on Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

Generex  Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of Direct-to-Patient Pharmacy Business MIRAMAR, Fla., […]

Healthcare

Soligenix, Inc (NASDAQ: SNGX) CEO Dr. Chris Schaber talks about their two Phase III trials and upcoming interim analysis

May 7, 2019 The Wall Street Analyzer Comments Off on Soligenix, Inc (NASDAQ: SNGX) CEO Dr. Chris Schaber talks about their two Phase III trials and upcoming interim analysis

INTERVIEW HIGHLIGHTS: *Two Pivotal Phase III studies for T-cell Lymphoma and Oral mucositis *Enrollment milestone for SGX942 *Upcoming interim analysis for SGX942 in September *Top-line final results for CTCL expected in 1Q 2020 INTERVIEW SUMMARY: […]